EVV_157-26_KBM_Lijekovi epkoritamab, kaplacizumab
TED · 708852-2026Preliminary market consultationNo deadline given
Value
Estimated€273,157 · 273,157.06 EUR
Awarded—
Who already wins at this buyer
Firms with recorded awards from Klinička bolnica Merkur in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MEDIKA, d.d. | 5 | €1,883,139 | 2026-10-01 |
| MEDICAL INTERTRADE d.o.o. | 2 | €220,778 | 2026-05-27 |
| SOFMEDICA CROATIA d.o.o. | 1 | €3,497,019 | 2026-08-18 |
| BioGnost d.o.o. | A & B d.o.o. | HEBE, d.o.o. | ROCHE d.o.o. | BIOMEDICA DIJAGNOSTIKA d.o.o. | Altium International d.o.o. | Digicyte digitalne tehnologije d.o.o. | Astrafokus d.o.o. | PRIMAT-LOGISTIKA d.o.o. | 1 | €1,451,982 | 2026-10-05 |
| BioGnost d.o.o. | A & B d.o.o. | HEBE, d.o.o. | BIOMEDICA DIJAGNOSTIKA d.o.o. | Altium International d.o.o. | Digicyte digitalne tehnologije d.o.o. | Astrafokus d.o.o. | PRIMAT-LOGISTIKA d.o.o. | 1 | €1,360,982 | 2026-09-25 |
Full buyer profile: what Klinička bolnica Merkur buys and who wins it →
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
Predmet postupka je sukcesivna nabava lijekova epkoritamab, kaplacizumab. Nabava je podijeljena na grupe. Količine navedene u Troškovniku su predviđene (okvirne) količine za ugovorno razdoblje. GRUPA 1. epkoritamab PVN 192.784,06 GRUPA 2. kaplacizumab PVN 80.373,00